Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards, and cell therapy.

The Quasi Vivo® Device consists of an advanced, interconnected fluidics system to create more physiologically relevant cell-culture conditions, helping researchers improve the predictive value of their studies.

Gilson announces launch of their cloud-connected platform powering new tools to help researchers achieve verifiable science. Tablet with microplate app and electronic pipette are first Internet of Things devices in the Gilson Connect Family.

Thermo Fisher Scientific, the world leader in serving science, today announced new laboratory automation technologies designed to streamline workflows, optimize productivity, and speed time to results.

Advanced analytics and remote diagnostics wireless cold storage monitoring solution voted most innovative product of 2017.

The Good Liquid HandlingTM Kits provide users with everything necessary to verify and calibrate their systems to industry standards. They provide reliable instrument services, products, and training. Kits are medically manufactured to ensure quality and performance.

Lonza will present two posters highlighting its latest research into developing more physiologically relevant in vitro cell-culture models for ADME-Tox testing.

New liquid handling platform reduces assay development time and improves assay robustness in high throughput screening. Global commercial launch at SLAS 2018 from 3rd to 7th February 2018, in San Diego, CA, Booth #1219

Radical expansion of rental program availability highlighted at leading industry event.

First GE Healthcare FlexFactory™ for cell therapy installation in the world expected to provide CBMG with scalable, fully-equipped cell therapy manufacturing capabilities, training and services.